CIK 0001599298 · Large accelerated filer
Summit Therapeutics Inc.
Sign in to watch- Ticker
- SMMT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 371979717
- Phone
- 305-203-2034
- Business address
- 601 BRICKELL KEY DRIVE, SUITE 1000, MIAMI, FL, 33131
- Former names
- Summit Therapeutics plc, Summit Corp plc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 8 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-02 | Clark Kenneth A Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2025-01-02 | Clark Kenneth A Director | Grant or award · Stock Option (right to buy) | +16,991 | $9.18 | $156K | 16,991 |
| 2025-01-02 | Booth Robert F. Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2025-01-02 | Booth Robert F. Director | Grant or award · Stock Option (right to buy) | +6,855 | $9.18 | $63K | 6,855 |
| 2024-10-11 | Clark Kenneth A Director | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2024-10-03 | Zanganeh Mahkam Co-Chief Executive Officer | Option exercise | +315,681 | $1.58 | $499K | 10,199,776 |
| 2024-10-03 | Zanganeh Mahkam Co-Chief Executive Officer | Option exercise · Warrant (right to buy) | −315,681 | 0 | ||
| 2024-09-11 | Zanganeh Mahkam Co-Chief Executive Officer | Grant or award | +44,052 | $22.70 | $1000K | 24,967,852 |
| 2024-09-11 | DUGGAN ROBERT W Co-Chief Executive Officer | Grant or award | +3,325,991 | $22.70 | $75.5M | 551,695,096 |
| 2024-09-11 | Huber Jeff Director | Grant or award | +44,052 | $22.70 | $1000K | 44,052 |
| 2024-09-11 | Soni Manmeet Singh COO and CFO | Grant or award | +44,052 | $22.70 | $1000K | 3,020,242 |
| 2024-09-11 | Anand Bhaskar Chief Accounting Officer | Grant or award | +22,026 | $22.70 | $500K | 131,426 |
| 2024-08-23 | Soni Manmeet Singh COO and CFO | Grant or award · Performance Stock Option (right to buy) | +2,800,000 | 2,800,000 | ||
| 2024-08-23 | Zanganeh Mahkam Chief Executive Officer | Grant or award · Performance Stock Option (right to buy) | +260,000 | 260,000 | ||
| 2024-08-23 | Zanganeh Mahkam Chief Executive Officer | Grant or award · Performance Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2024-08-23 | Zanganeh Mahkam Chief Executive Officer | Grant or award · Performance Stock Option (right to buy) | +2,397,640 | 2,397,640 | ||
| 2024-06-27 | Huber Jeff Director | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2024-06-27 | Huber Jeff Director | Grant or award · Stock Option (right to buy) | +17,883 | 217,883 | ||
| 2024-04-11 | Ronaghi Mostafa Director | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2024-04-11 | Ronaghi Mostafa Director | Grant or award · Stock Option (right to buy) | +25,315 | 225,315 |
Page 4 of 9 · 163 trades